Last reviewed · How we verify
NCT04248777: LEMON
Optical Coherence Tomography - Guided Protocol for Left Main Percutaneous Coronary Intervention
NA trial testing standardised OCT-guided intervention in Left Main Coronary Artery Stenosis in 71 participants. Completed in 1 February 2019.
28 January 2019
Quick facts
| Lead sponsor | Institut Mutualiste Montsouris |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 71 |
| Start date | 18 May 2018 |
| Primary completion | 28 January 2019 |
| Estimated completion | 1 February 2019 |
| Sites | 11 locations across France |
Drugs / interventions tested
- standardised OCT-guided intervention
Conditions studied
- Left Main Coronary Artery Stenosis — all drugs for Left Main Coronary Artery Stenosis →
Sponsor
Institut Mutualiste Montsouris — full company profile →
Who can join
18 and older, any sex, with Left Main Coronary Artery Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
LEMON aim is to evaluate the feasibility, efficiency and security of a standardized Optical Coherence Tomography (OCT) - guided protocol for completion and optimization of Left Main (LM) Percutaneous Coronary Intervention (PCI).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Optical coherence tomography to guide percutaneous coronary intervention of the left main coronary artery: the LEMON study.
Amabile N, Rangé G, Souteyrand G, Godin M, et al · · 2021 · cited 46× · PMID 33226003 · DOI 10.4244/eij-d-20-01121
Verify or expand the search:
- PubMed search for NCT04248777
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Left Main Coronary Artery Stenosis
Currently open trials in the same condition.
- NCT05650411 — Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs · NA · recruiting
- NCT03767621 — Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospecti · active not recruiting
Other Institut Mutualiste Montsouris trials
Trials by the same sponsor.
- NCT06982625 — Supra Inguinal Fascia Iliaca Block as Rescue Analgesia Following Total Hip Arthroplasty · NA · recruiting
- NCT06007274 — Troponin to Detect Major Cardiovasculaire Advserse Events on Immune Checkpoint Inhibitors · completed
- NCT06020651 — Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside · NA · completed
- NCT05799898 — Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors · recruiting
- NCT05301218 — CAlcified Lesion Intervention Planning Steered by OCT. · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04248777 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut Mutualiste Montsouris
- Last refreshed: 30 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04248777.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing